New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

As a physician, researcher, and biotech leader with personal experience of prostate cancer in my family, I’ve long advocated for putting patients first in our quest for medical innovation. Today, I ...

Obesity and prostate cancer are two very common diagnoses in older men, and several studies have found a relationship between excess weight and prostate cancer progression. “The diagnosis of cancer is ...

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized ...

A new product called iQuest has the potential to define the extent of cancer more accurately. Personalized medicine for prostate cancer is becoming more of a reality for a larger number of men thanks ...

Study finds substantial concordance between PSMA-PET and conventional imaging for primary prostate cancer staging. Using prostate-specific membrane antigen positron emission tomography (PSMA-PET) for ...

What The 2024 NCCN Guidelines Say About... It does if a single state in the U.S. is any indication. In North Carolina, significantly higher rates of prostate cancer recurrence were reported among men ...

Changes in planned disease management after piflufolastat F18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study. This ...

This special collection entitled “New trends on the management of localized prostate cancer” features articles recently published in Prostate Cancer and Prostatic Diseases (PCAN) covering some ...

Medanta – The Medicity has launched a prostate cancer awareness initiative titled ‘Socho Mat Baat Karo’ (SMBK). The campaign ...

Prostate cancers are given a score called a Gleason score that measures, on a scale of 1 to 10, how the cancerous cells look ...